Xindu Quality
The production of our special biotransformation mycelium raw materials has created the most favorable condition for development of all types of health care products. The company plans in the first period (2015-2017) to develop and market four categories and ten health care products.
Xinquan Xinlin, the parent company of Xindu Biological, has over 10 years of experience in the production and management of pharmaceuticals, with product quality QA / QC system and management advantages. The company appoints a technical director for product quality control, establishing and improving the management of all types of quality control systems.
Quality control checkpoint
Quality control will be ensured by a five-step management system
-
FDA Standard
Starting from product development to conduct the “standards” checkpoint by meeting or exceeding the relevant health care quality standards promulgated by the US FDA
-
Raw material procurement checkpoint
Substandard raw materials cannot be accepted for storage.
-
Raw material usage checkpoint
Substandard materials cannot enter the production pipeline.
-
Intermediate product checkpoint
Unqualified intermediate products cannot continue to the next production stage.
-
Final product checkpoint
Products that failed QC cannot be stored and shipped for sale.
Please feel free to contact with us if you have any quations regarding our production or services
- 496 Hwy 64E, Conway, AR. 72032
- Phone: 501 336 0077
- Fax: 800 750 8155
- Email: zhoulexue@xdmarket.com
Service Info
2024 © XIN DU BIO-TECH,LLC.. ALL Rights Reserved. Xindu | Privacy Policy | Terms of Service | Sales and Refunds